Yang Huang
Stock Analyst at J.P. Morgan
(4.83)
# 433
Out of 5,073 analysts
123
Total ratings
70.6%
Success rate
37.5%
Average return
Main Sectors:
Stocks Rated by Yang Huang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 1548 Genscript Biotech Corporation | Reiterated: Buy | $23.00 → $41.00 | $33.94 | +20.80% | 4 | Sep 17, 2026 | |
| HKG: 1801 Innovent Biologics, Inc. | Reiterated: Buy | $117.00 → $140.00 | $88.75 | +57.75% | 20 | Aug 27, 2026 | |
| HKG: 9995 RemeGen Co., Ltd. | Reiterated: Buy | $129.00 | $66.80 | +93.11% | 14 | Aug 6, 2026 | |
| HKG: 2359 WuXi AppTec Co., Ltd. | Reiterated: Buy | $138.00 → $150.00 | $195.20 | -23.16% | 11 | Mar 26, 2026 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Reiterated: Buy | $499.00 → $545.00 | $472.20 | +15.42% | 2 | Nov 24, 2025 | |
| HKG: 1877 Shanghai Junshi Biosciences Co., Ltd. | Reiterated: Sell | $18.00 → $20.00 | $17.21 | +16.21% | 9 | Oct 30, 2025 | |
| HKG: 3347 Hangzhou Tigermed Consulting Co., Ltd | Reiterated: Sell | $37.00 → $38.00 | $41.08 | -7.50% | 8 | Oct 29, 2025 | |
| HKG: 3692 Hansoh Pharmaceutical Group Company Limited | Initiated Coverage: Buy | $43.00 | $34.20 | n/a | 1 | Sep 25, 2025 | |
| HKG: 1276 Jiangsu Hengrui Pharmaceuticals Co.,Ltd | Initiated Coverage: Hold | $78.00 | $49.58 | n/a | 1 | Sep 23, 2025 | |
| HKG: 9926 Akeso, Inc. | Reiterated: Buy | $99.00 → $166.00 | $92.45 | n/a | 11 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36.00 → $37.00 | $49.16 | n/a | 10 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46.00 → $74.00 | $75.95 | n/a | 6 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52.00 → $93.00 | $31.16 | n/a | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84.00 → $80.00 | $38.84 | n/a | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $186.00 → $183.60 | $231.80 | n/a | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $3.40 | $1.49 | n/a | 1 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $217 → $64 | $25.08 | n/a | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $26.50 | $5.80 | n/a | 1 | Jan 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $4.80 → $3.00 | $1.69 | n/a | 3 | Jan 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14.00 | $8.68 | n/a | 4 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18.00 | $10.23 | n/a | 2 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $9.00 → $11.00 | $14.19 | n/a | 2 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 → $169 | $384.50 | n/a | 4 | Mar 26, 2020 |
Genscript Biotech Corporation
Sep 17, 2026
Reiterated: Buy
Price Target: $23.00 → $41.00
Current: $33.94
Upside: +20.80%
Innovent Biologics, Inc.
Aug 27, 2026
Reiterated: Buy
Price Target: $117.00 → $140.00
Current: $88.75
Upside: +57.75%
RemeGen Co., Ltd.
Aug 6, 2026
Reiterated: Buy
Price Target: $129.00
Current: $66.80
Upside: +93.11%
WuXi AppTec Co., Ltd.
Mar 26, 2026
Reiterated: Buy
Price Target: $138.00 → $150.00
Current: $195.20
Upside: -23.16%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Nov 24, 2025
Reiterated: Buy
Price Target: $499.00 → $545.00
Current: $472.20
Upside: +15.42%
Shanghai Junshi Biosciences Co., Ltd.
Oct 30, 2025
Reiterated: Sell
Price Target: $18.00 → $20.00
Current: $17.21
Upside: +16.21%
Hangzhou Tigermed Consulting Co., Ltd
Oct 29, 2025
Reiterated: Sell
Price Target: $37.00 → $38.00
Current: $41.08
Upside: -7.50%
Hansoh Pharmaceutical Group Company Limited
Sep 25, 2025
Initiated Coverage: Buy
Price Target: $43.00
Current: $34.20
Upside: n/a
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Sep 23, 2025
Initiated Coverage: Hold
Price Target: $78.00
Current: $49.58
Upside: n/a
Akeso, Inc.
Aug 27, 2025
Reiterated: Buy
Price Target: $99.00 → $166.00
Current: $92.45
Upside: n/a
Aug 21, 2025
Reiterated: Buy
Price Target: $36.00 → $37.00
Current: $49.16
Upside: n/a
Aug 14, 2025
Reiterated: Buy
Price Target: $46.00 → $74.00
Current: $75.95
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $52.00 → $93.00
Current: $31.16
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $84.00 → $80.00
Current: $38.84
Upside: n/a
Mar 7, 2023
Reiterated: Buy
Price Target: $186.00 → $183.60
Current: $231.80
Upside: n/a
Feb 22, 2023
Upgraded: Buy
Price Target: $3.40
Current: $1.49
Upside: n/a
Nov 14, 2022
Reiterated: Buy
Price Target: $217 → $64
Current: $25.08
Upside: n/a
Jan 6, 2022
Downgraded: Sell
Price Target: $26.50
Current: $5.80
Upside: n/a
Jan 6, 2022
Downgraded: Sell
Price Target: $4.80 → $3.00
Current: $1.69
Upside: n/a
Aug 31, 2021
Reiterated: Buy
Price Target: $14.00
Current: $8.68
Upside: n/a
Aug 27, 2021
Reiterated: Hold
Price Target: $18.00
Current: $10.23
Upside: n/a
Jun 29, 2021
Downgraded: Hold
Price Target: $9.00 → $11.00
Current: $14.19
Upside: n/a
Mar 26, 2020
Reiterated: Buy
Price Target: $230 → $169
Current: $384.50
Upside: n/a